Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1028-1034

  Giménez Barcons, Mireia ^a   Forns, Xavier ^a   Ampurdanés, Sergi ^a   Guilera, Magda ^a   Soler, Marta ^a   Soguero, Carolina ^a   Sánchez Fueyo, Alberto ^a   Mas, Antoni ^a   Bruix, Jordi ^a   Sánchez Tapias, José María ^a   Rodés, Juan ^a   Saiz, Juan Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chronic hepatitis; Cryptogenic hepatitis; Fulminant hepatitis; Hepatocellular carcinoma; TTV types

Indexed keywords

INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DNA VIRUS; DRUG RESPONSE; FEMALE; HEPATITIS; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SPAIN; VIRUS INFECTION;

EID: 0345210944     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80256-6     Document Type: Article

References (27)

1. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to hepatitis C virus (Non ABC). Semin Liver Dis. 15:1995;110-120.
2. Kodali VP, Gordon SC, Silverman A, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol. 89:1994;1836-1839.
3. Marcellin P, Matinot-Peignoux M, Gabriel F, Branger M, Degott C, Elias A, et al. Chronic non B-non C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. J Hepatol. 19:1993;167-170.
4. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of a novel virus-like sequences associated with human hepatitis. Nat Med. 1:1995;564-569.
5. Linnen J, Wages J, Zhong-Keck Z-Y, Fry E, Krawczynski KZ, Alter HL, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
6. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown etiology. Lancet. 346:1996;1131-1132.
7. Saiz JC, Sans M, Mas A, Olmedo E, Forns X, López-Labrador FX, et al. Hepatitis G virus infection in fulminant hepatic failure. Gut. 41:1997;696-699.
8. Guilera M, Saiz JC, López-Labrador FX, Olmedo A, Ampurdanés S, Forns X, et al. Hepatitis G virus infection in chronic liver disease. Gut. 42:1998;107-111.
9. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on hepatitis G virus. Transfusion. 37:1997;569-572.
10. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 241:1997;92-97.
11. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H. Molecular cloning and characterization of a novel DNA virus (TTV) associated with postransfusion hepatitis of unknown etiology. Hepatol Res. 10:1998;1-16.
12. Simmonds P, Davidson F, Lycett C, Prescott LE, Mac Donald DM, Ellender J, et al. Detection of a novel DNA virus (TT virus) in blood donors and blood products. Lancet. 352:1988;191-194.
13. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet. 352:1998;195-197.
14. Charlton M, Adjel P, Poterucha J, Zein N, Moore B, Therneau T, et al. TT-Virus infection in North American Blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 28:1998;839-842.
15. Trey C, Davidson LS. The management of fulminant hepatic failure. Popper H, Schaffner F, . Progress in Liver Disease. 1970;282-298 Grune and Stratton, New York.
16. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 343:1993;273-275.
17. Costa J, López-Labrador FX, Sánchez-Tapias JM, Mas A, Vilella A, Olmedo E, et al. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol. 22:1995;35-42.
18. Lindh M, Anderson A-S, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis. 175:1997;1285-1293.
19. Sánchez-Tapias JM, Forns X, Ampurdanés S, Titó Ll, Planas R, Vives JM, et al. Low-dose alpha-interferon therapy can be effective in chronic hepatitis C results of a multicentre, randomized trial. Gut. 38:1996;603-609.
20. Olmedo E, Costa J, López-Labrador FX, Ampurdanés S, Maluenda MD, Guilera M, et al, Comparative study of a modified RT-PCR an d amplicor HCV monitor assays for quantification of Hepatitis C virus RNA in serum, J Med Virol (in press)
21. López-Labrador FX, Ampurdanés S, Forns X, Castells A, Saiz JC, Costa J, et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol. 27:1997;959-965.
22. Saiz JC, Ampurdanés S, Olmedo E, López-Labrador FX, Forns X, Guilera M, et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol. 26:1997;787-793.
23. Thompson JD, Iliggins GD, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignments through sequence weighting position-specific gap penalties and weight matrix choice. Nucl Acids Res. 22:1994;4673-4680.
24. Felsenstein J. Phylogenies from molecular sequences: inference and reliability. Ann Rev Genet. 22:1988;521-565.
25. Felsenstein J. Phylogeny Inference Package (PHYLIP), version 3.75 c. University of Washington, Seattle. 1995.
26. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 39:1985;783-791.
27. Page RDM. TREEVIEW: an application to display phylogenetic trees on personal computers. Comput Appl Biosci. 12:1996;53-60.